Device type · NIQ
Coronary Drug-Eluting Stent
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NIQ
Cardiovascular
Device class
Class III
FDA decisions since 2015
18
510(k), De Novo and PMA
Adverse event reports
2,656
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Coronary Drug-Eluting Stent
- Product code
- NIQ
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Interventional Cardiology
- FDA record
- Classification database entry for NIQ
Latest FDA decisions
The 8 newest of 18 since 2015.
- SYNERGY XD Everolimus Eluting Platinum Chromium Coronary Stent System, SYNERGY SHIELD Everolimus Eluting Platinum ChromiPMA supplement
P150003-S105 · Decided Jan 27, 2025 · 180 days after receipt · Panel Track
Device type: Coronary drug-eluting stent (NIQ) · Cardiology
- Resolute Onyx Zotarolimus-Eluting Coronary Stent System, Onyx Frontier Zotarolimus-Eluting Coronary Stent SystemPMA supplement
P160043-S058 · Decided Sep 15, 2022 · 190 days after receipt · Panel Track
Device type: Coronary drug-eluting stent (NIQ) · Cardiology
Biosensors International USA, Inc.
P190020 · Decided Apr 14, 2022 · 972 days after receipt
Device type: Coronary drug-eluting stent (NIQ) · Cardiology
Advanced Bifurcation Systems, Inc.
P210014 · Decided Dec 13, 2021 · 256 days after receipt
Device type: Coronary drug-eluting stent (NIQ) · Cardiology
- XIENCE Alpine Everolimus Eluting Coronary Stent Systems (XIENCE Alpine EECSS), XIENCE Sierra Everolimus Eluting CoronaryPMA supplement
P110019-S115 · Decided Jun 25, 2021 · 179 days after receipt · Panel Track
Device type: Coronary drug-eluting stent (NIQ) · Cardiology
- Resolute Onyx Zotarolimus-Eluting Coronary Stent SystemPMA supplement
P160043-S034 · Decided Sep 22, 2020 · 179 days after receipt · Panel Track
Device type: Coronary drug-eluting stent (NIQ) · Cardiology
- Synergy Everolimus-Eluting Platinum Chromium Coronary Stent System (Monorail and Over-The-Wire)PMA supplement
P150003-S058 · Decided Aug 10, 2020 · 249 days after receipt · Panel Track
Device type: Coronary drug-eluting stent (NIQ) · Cardiology
P170030 · Decided Feb 22, 2019 · 513 days after receipt
Device type: Coronary drug-eluting stent (NIQ) · Cardiology
Reports received
2,656
Received Nov 1, 2025 to Nov 19, 2026. Includes 7 of another or unstated type.
Malfunction reports
1,473
55% of reports
Injury reports
1,040
39% of reports
Death reports
136
5.1% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 123 | 79 | 16 | 0 |
| Jan 24 | 128 | 140 | 18 | 0 |
| Feb 24 | 162 | 102 | 12 | 0 |
| Mar 24 | 156 | 108 | 13 | 0 |
| Apr 24 | 124 | 111 | 14 | 0 |
| May 24 | 124 | 153 | 30 | 0 |
| Jun 24 | 108 | 105 | 10 | 0 |
| Jul 24 | 116 | 77 | 4 | 0 |
| Aug 24 | 101 | 111 | 13 | 0 |
| Sep 24 | 107 | 122 | 18 | 1 |
| Oct 24 | 107 | 121 | 17 | 0 |
| Nov 24 | 116 | 139 | 14 | 0 |
| Dec 24 | 91 | 143 | 5 | 0 |
| Jan 25 | 101 | 107 | 12 | 0 |
| Feb 25 | 101 | 113 | 16 | 0 |
| Mar 25 | 94 | 88 | 15 | 2 |
| Apr 25 | 84 | 107 | 9 | 0 |
| May 25 | 79 | 129 | 14 | 0 |
| Jun 25 | 89 | 73 | 9 | 0 |
| Jul 25 | 103 | 74 | 20 | 0 |
| Aug 25 | 105 | 129 | 40 | 0 |
| Sep 25 | 98 | 77 | 9 | 0 |
| Oct 25 | 81 | 119 | 16 | 0 |
| Nov 25 | 91 | 66 | 7 | 1 |
| Dec 25 | 117 | 92 | 13 | 0 |
| Jan 26 | 121 | 89 | 16 | 0 |
| Feb 26 | 102 | 80 | 7 | 0 |
| Mar 26 | 145 | 109 | 16 | 0 |
| Apr 26 | 164 | 63 | 6 | 0 |
| May 26 | 138 | 86 | 17 | 0 |
| Jun 26 | 119 | 84 | 10 | 0 |
| Jul 26 | 142 | 105 | 20 | 1 |
| Aug 26 | 114 | 88 | 12 | 2 |
| Sep 26 | 111 | 100 | 6 | 3 |
| Oct 26 | 109 | 78 | 6 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem806
- Material Deformation525
- Failure to Advance506
- Device Dislodged or Dislocated398
- Positioning Problem204
- Break195
- Difficult to Remove161
- Nonstandard Device143
- Difficult to Advance142
- Fracture97
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions1,663
- Vascular Dissection486
- Thrombosis/Thrombus119
- Myocardial Infarction109
- Obstruction/Occlusion80
- Chest Pain75
- Restenosis74
- Reduced Blood Flow67
- Cardiac Arrest57
- Foreign Body In Patient54
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2370-2020 · Started Mar 25, 2020
Reason given: Incorrect expiration date
Cause as FDA categorized it: Incorrect or no expiration date
Z-0154-2014 · Started Oct 7, 2013 · Posted by FDA Nov 5, 2013
Reason given: A small number of units in lot number 0006573585 of the Resolute Integrity Zotarolimus-Eluting Coronary Sten System may contain a compliance chart incorrectly referencing a 2.25 mm diameter instead of the correct 3.0mm.
Cause as FDA categorized it: Process control
Medtronic Vascular Galway Limited
Z-1367-2011 · Started Aug 6, 2009 · Posted by FDA Aug 21, 2009
Reason given: The product was removed from investigational sites due to a packaging issue, in that the device units were packed without the foil pouch, oxygen absorber and Instructions For Use.
Cause as FDA categorized it: Packaging
Z-0437-05 · Started Jan 12, 2005 · Posted by FDA Jan 26, 2005
Reason given: Six of 370 stents released to market had a slightly below the required polymeric coating weight. All other specification were met.
Cause as FDA categorized it: Other
Z-0555-05 · Started Nov 18, 2004 · Posted by FDA Feb 18, 2005
Reason given: Inventory control stickers had incorrect expiration date. The stickers stated the expiration date was November 2004 instead of October 2004.
Cause as FDA categorized it: Other
Z-1052-04 · Started Jul 1, 2004 · Posted by FDA Jul 20, 2004
Reason given: On a few occasions the balloon has failed to deflate within one minute after deployment of the stent.
Cause as FDA categorized it: Other
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.